Safety and feasibility of minimally invasive inguinal lymph node dissection in patients with melanoma (SAFE-MILND): Report of a prospective multi-institutional trial

Annals of Surgery

Volumn 265, Issue 1, 2017, Pages 192-196

  Jakub, James W ^a   Terando, Alicia M ^b   Sarnaik, Amod ^c   Ariyan, Charlotte E ^d   Faries, Mark B ^e   Zani, Sabino ^f   Neuman, Heather B ^g   Wasif, Nabil ^h   Farma, Jeffrey M ⁱ   Averbook, Bruce J ^j   Bilimoria, Karl Y ^k   Grotz, Travis E ^a   Allred, Jacob B Jake ^a   Suman, Vera J ^a   Brady, Mary Sue ^d   Tyler, Douglas ^c   Wayne, Jeffrey D ^l   Nelson, Heidi ^a  

^a MAYO CLINIC   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^c H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^d MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^e JOHN WAYNE CANCER INSTITUTE   (United States)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^h MAYO CLINIC   (United States)

ⁱ FOX CHASE CANCER CENTER   (United States)

^j METROHEALTH MEDICAL CENTER   (United States)

^k NORTHWESTERN UNIVERSITY   (United States)

^l University of Texas Medical Branch School of Medicine   (United States)

more..

Author keywords

Benchmarks; Complications; Endoscopic; Groin dissection; Inguinal; Laparoscopic; Lymph node count; Melanoma; Minimally invasive; Seroma; Videoscopic; Wound infection

Indexed keywords

ADULT; ARTICLE; BLEEDING; FEASIBILITY STUDY; FEMALE; HUMAN; INGUINAL LYMPH NODE; LYMPH NODE DISSECTION; LYMPHEDEMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; MINIMALLY INVASIVE SURGERY; MOTOR NEUROPATHY; NATIONAL HEALTH ORGANIZATION; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SAFETY; SEROMA; SKIN INJURY; SKIN NECROSIS; SPECIALIZATION; SURGEON; SURGICAL TRAINING; WOUND DEHISCENCE; WOUND INFECTION; ADOLESCENT; AGED; CLINICAL TRIAL; FOLLOW UP; INGUINAL REGION; LYMPH NODE METASTASIS; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PATIENT SAFETY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PROCEDURES; SKIN NEOPLASMS; TREATMENT OUTCOME; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEASIBILITY STUDIES; FEMALE; FOLLOW-UP STUDIES; GROIN; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MALE; MELANOMA; MIDDLE AGED; MINIMALLY INVASIVE SURGICAL PROCEDURES; PATIENT SAFETY; PROSPECTIVE STUDIES; SKIN NEOPLASMS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84959246803     PISSN: 00034932     EISSN: 15281140     Source Type: Journal    
DOI: 10.1097/SLA.0000000000001670     Document Type: Article

References (33)

1. Giuliano AE, McCall L, Beitsch P, et al. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: The American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg. 2010; 252: 426-432.
2. Morton DL, Thompson JF, Cochran AJ, et al. Final trial report of sentinel-node biopsy versus nodal observation in melanoma. N Engl J Med. 2014; 370: 599-609.
3. Chang SB, Askew RL, Xing Y, et al. Prospective assessment of postoperative complications and associated costs following inguinal lymph node dissection (ILND) in melanoma patients. Ann Surg Oncol. 2010; 17: 2764-2772.
4. Coit DG, Peters M, Brennan MF. A prospective randomized trial of perioperative cefazolin treatment in axillary and groin dissection. Arch Surg. 1991; 126: 1366-1371.
5. Serpell JW, Carne PW, Bailey M. Radical lymph node dissection for melanoma. ANZ J Surg. 2003; 73: 294-299.
6. Mortenson MM, Xing Y, Weaver S, et al. Fibrin sealant does not decrease seroma output or time to drain removal following inguino-femoral lymph node dissection in melanoma patients: A randomized controlled trial (NCT00506311). World J Surg Oncol. 2008; 6: 63.
7. Sarnaik AA, Puleo CA, Zager JS, et al. Limiting the morbidity of inguinal lymphadenectomy for metastatic melanoma. Cancer Control. 2009; 16: 240-247.
8. Sabel MS, Griffith KA, Arora A, et al. Inguinal node dissection for melanoma in the era of sentinel lymph node biopsy. Surgery. 2007; 141: 728-735.
9. Bishoff JT, Teichman BJ, Thompson JM, IM. Endoscopy subcutaneous modified inguinal lymph node dissection (ESMIL) for squamous cell carcinoma of the penis. J Urol. 2003; 169: 78 [abstract 301].
10. Tobias-Machado M, Tavares A, Molina WR Jr, et al. Video endoscopic inguinal lymphadenectomy (VEIL): Minimally invasive resection of inguinal lymph nodes. Int Braz J Urol. 2006; 32: 316-321.
11. Delman KA, Kooby DA, Ogan K, et al. Feasibility of a novel approach to inguinal lymphadenectomy: Minimally invasive groin dissection for melanoma. Ann Surg Oncol. 2010; 17: 731-737.
12. Abbott AM, Grotz TE, Rueth NM, et al. Minimally invasive inguinal lymph node dissection (MILND) for melanoma: Experience from two academic centers. Ann Surg Oncol. 2013; 20: 340-345.
13. Martin BM, Etra JW, Russell MC, et al. Oncologic outcomes of patients undergoing videoscopic inguinal lymphadenectomy for metastatic melanoma. J Am Coll Surg. 2014; 218: 620-626.
14. Cheville AL, McGarvey CL, Petrek JA, et al. The grading of lymphedema in oncology clinical trials. Sem Radiat Oncol. 2003; 13: 214-225.
15. Armer JM, Stewart BR. A comparison of four diagnostic criteria for lymphedema in a post-breast cancer population. Lymphat Res Biol. 2005; 3: 208-217.
16. Armer JM, Stewart BR, Shook RP. 30-Month post-breast cancer treatment lymphoedema. J Lymphoedema. 2009; 4: 14-18.
17. Schmitz KH, Ahmed RL, Troxel A, et al.Weight lifting in women with breastcancer- related lymphedema. N Eng J Med. 2009; 361: 664-673.
18. Schmitz KH, Ahmed RL, Troxel AB, et al.Weight lifting for women at risk for breast cancer-related lymphedema: A randomized trial. JAMA. 2010; 304: 2699-2705.
19. Balch CM, Durant JR, Bartolucci AA. The impact of surgical quality control in multi-institutional group trials involving adjuvant cancer treatments. Ann Surg. 1983; 198: 164-167.
20. Grotz TE, Huebner M, Pockaj BA, et al. Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma. Ann Surg Oncol. 2013; 20: 4370-4377.
21. Bilimoria KY, Balch CM, Bentrem DJ, et al. Complete lymph node dissection for sentinel node-positive melanoma: Assessment of practice patterns in the United States. Ann Surg Oncol. 2008; 15: 1566-1576.
22. Xing Y, Badgwell BD, Ross MI, et al. Lymph node ratio predicts diseasespecific survival in melanoma patients. Cancer. 2009; 115: 2505-2513.
23. Rossi CR, Mozzillo N, Maurichi A, et al. The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis. Ann Oncol. 2014; 25: 240-246.
24. Spillane AJ, Cheung BL, Stretch JR, et al. Proposed quality standards for regional lymph node dissections in patients with melanoma. Ann Surg. 2009; 249: 473-480.
25. Galliot-Repkat C, Cailliod R, Trost O, et al. The prognostic impact of the extent of lymph node dissection in patients with stage III melanoma. Eur J Surg Oncol. 2006; 32: 790-794.
26. Spillane AJ, Haydu L, McMillan W, et al. Quality assurance parameters and predictors of outcome for ilioinguinal and inguinal dissection in a contemporary melanoma patient population. Ann Surg Oncol. 2011; 18: 2521-2528.
27. Egger ME, Brown RE, Roach BA, et al. Addition of an iliac/obturator lymph node dissection does not improve nodal recurrence or survival in melanoma. J Am Coll Surg. 2014; 219: 101-108.
28. Jakub JW, Terando AM, Sarnaik A, et al. Training high volume melanoma surgeons to perform a novel minimally invasive inguinal lymphadenectomy: Report of a prospective multi-institutional trial. JACS. 2016 (in press).
29. Faries MB, Thompson JF, Cochran A, et al. The impact on morbidity and length of stay of early versus delayed complete lymphadenectomy in melanoma: Results of the Multicenter Selective Lymphadenectomy Trial (I). Ann Surg Oncol. 2010; 17: 3324-3329.
30. Martin BM, Master VA, Delman KA. Videoscopic inguinal lymphadenectomy for metastatic melanoma. Cancer Control. 2013; 20: 255-260.
31. James JH. Lymphoedema following ilio-inguinal lymph node dissection. Scand J Plast Reconstr Surg. 1982; 16: 167-171.
32. Burmeister BH, Smithers BM, Davis S, et al. Radiation therapy following nodal surgery for melanoma: An analysis of late toxicity. ANZ J Surg. 2002; 72: 344-348.
33. Spillane AJ, Saw RP, Tucker M, et al. Defining lower limb lymphedema after inguinal or ilio-inguinal dissection in patients with melanoma using classification and regression tree analysis. Ann Surg. 2008; 248: 286-293.